Wanchun Tang Selected Research

Heart Arrest (Cardiac Arrest)

7/2022	Necrosulfonamide improves post-resuscitation myocardial dysfunction via inhibiting pyroptosis and necroptosis in a rat model of cardiac arrest.
2/2022	Quantitative magnetic resonance imaging assessment of brain injury after successful cardiopulmonary resuscitation in a rat model of asphyxia cardiac arrest.
1/2022	The Selective NLRP3-inflammasome inhibitor MCC950 Mitigates Post-resuscitation Myocardial Dysfunction and Improves Survival in a Rat Model of Cardiac Arrest and Resuscitation.
1/2022	Exogenous Nicotinamide Adenine Dinucleotide Attenuates Postresuscitation Myocardial and Neurologic Dysfunction in a Rat Model of Cardiac Arrest.
1/2022	UAMC-3203 or/and Deferoxamine Improve Post-Resuscitation Myocardial Dysfunction Through Suppressing Ferroptosis in a Rat Model of Cardiac Arrest.
11/2021	Effects of NLRP3 inflammasome blockade on postresuscitation cerebral function in a rat model of cardiopulmonary resuscitation.
10/2021	High-resolution respirometry for evaluation of mitochondrial function on brain and heart homogenates in a rat model of cardiac arrest and cardiopulmonary resuscitation.
8/2021	Cerebral and myocardial mitochondrial injury differ in a rat model of cardiac arrest and cardiopulmonary resuscitation.
7/2021	Polyethylene glycol-20k reduces post-resuscitation cerebral dysfunction in a rat model of cardiac arrest and resuscitation: A potential mechanism.
1/2021	Effects of ω-3 PUFA and ascorbic acid combination on post-resuscitation myocardial function.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wanchun Tang Research Topics

Disease

97	Heart Arrest (Cardiac Arrest) 07/2022 - 01/2002
80	Ventricular Fibrillation 07/2022 - 04/2002
30	Shock 10/2021 - 04/2002
22	Hypothermia 01/2021 - 11/2008
16	Ischemia 01/2021 - 04/2003
10	Myocardial Ischemia (Ischemic Heart Diseases) 03/2012 - 04/2002
7	Reperfusion Injury 11/2021 - 12/2006
7	Hemorrhagic Shock 11/2018 - 04/2005
6	Neurologic Manifestations (Neurological Manifestations) 01/2022 - 06/2005
6	Sepsis (Septicemia) 01/2019 - 02/2006
5	Hemorrhage 12/2011 - 01/2006
4	Brain Ischemia (Cerebral Ischemia) 11/2021 - 09/2007
3	Brain Edema (Cerebral Edema) 02/2022 - 07/2021
3	Inflammation (Inflammations) 01/2021 - 01/2019
3	Wounds and Injuries (Trauma) 01/2019 - 02/2014
3	Hypoxia (Hypoxemia) 06/2017 - 06/2003
3	Myocardial Infarction 05/2011 - 03/2009
3	Cardiac Arrhythmias (Arrythmia) 05/2011 - 12/2006
2	Brain Injuries (Brain Injury) 02/2022 - 01/2018
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2020 - 01/2018
2	Cardiomegaly (Heart Hypertrophy) 06/2015 - 05/2014
2	Out-of-Hospital Cardiac Arrest 12/2013 - 05/2003
2	Left Ventricular Dysfunction 01/2013 - 01/2008
2	Hypotension (Low Blood Pressure) 12/2011 - 01/2009
2	Cardiogenic Shock 01/2011 - 08/2009
2	Septic Shock (Toxic Shock Syndrome) 01/2009 - 12/2006
2	Sudden Death 01/2008 - 02/2004
2	Coronary Occlusion 03/2007 - 07/2002
1	Asphyxia (Suffocation) 02/2022

Drug/Important Bio-Agent (IBA)

16	salicylhydroxamic acid (SHAM)IBA 01/2022 - 09/2002
14	Epinephrine (Adrenaline)FDA LinkGeneric 10/2021 - 07/2002
9	Adrenergic Agents (Adrenergic Drugs)IBA 01/2009 - 07/2002
7	Lactic Acid (Lactate)FDA LinkGeneric 01/2018 - 01/2006
7	Oxygen (Dioxygen)IBA 12/2015 - 05/2005
6	Amsacrine (AMSA)IBA 09/2019 - 04/2002
6	Carbon DioxideIBA 01/2019 - 06/2003
4	Polyethylene (Polythene)IBA 07/2021 - 12/2018
4	Indicators and Reagents (Reagents)IBA 12/2011 - 04/2005
4	SolutionsIBA 05/2011 - 01/2006
3	N- (1,2,3,5,6,7- hexahydro- S- indacen- 4- ylcarbamoyl)- 4- (2- hydroxy- 2- propanyl)- 2- furansulfonamideIBA 01/2022 - 01/2021
3	CalciumIBA 08/2021 - 04/2002
3	Adenosine Triphosphate (ATP)IBA 01/2018 - 03/2012
3	Free RadicalsIBA 12/2015 - 02/2004
3	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 08/2011 - 10/2002
3	Phosphates (Orthophosphate)IBA 05/2011 - 11/2008
3	BuffersIBA 05/2011 - 11/2008
3	Pentazocine (Talwin)FDA LinkGeneric 06/2010 - 10/2006
3	Propranolol (Inderal)FDA LinkGeneric 01/2009 - 09/2004
2	diazonaphthalenedisulfonic acid (NDS)IBA 01/2022 - 06/2017
2	InflammasomesIBA 11/2021 - 01/2020
2	Ascorbic Acid (Vitamin C)FDA LinkGeneric 01/2021 - 12/2008
2	Cannabinoid Receptor AgonistsIBA 12/2020 - 01/2014
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020 - 01/2018
2	CytokinesIBA 01/2019 - 01/2019
2	Neuroprotective AgentsIBA 01/2018 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 01/2018 - 06/2015
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 01/2018
2	Troponin IIBA 01/2018 - 05/2003
2	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 06/2015 - 05/2014
2	CannabinoidsIBA 09/2012 - 12/2010
2	Opioid Receptors (Opioid Receptor)IBA 03/2011 - 06/2010
2	Pharmaceutical PreparationsIBA 03/2011 - 09/2005
2	Vasopressins (Vasopressin)IBA 09/2007 - 11/2003
2	delta Opioid Receptors (delta Opioid Receptor)IBA 12/2006 - 10/2006
2	Dobutamine FDA LinkGeneric 11/2005 - 03/2005
2	Simendan (Levosimendan)IBA 09/2005 - 03/2005
2	SodiumIBA 07/2002 - 04/2002
2	cariporideIBA 07/2002 - 04/2002
1	N- (4- (N- (3- methoxypyrazin- 2- yl)sulfamoyl)phenyl)- 3- (5- nitrothiophene- 2- yl)acrylamideIBA 07/2022
1	NAD (NADH)IBA 01/2022
1	Niacinamide (Nicotinamide)FDA LinkGeneric 01/2022
1	Deferoxamine (Desferal)FDA LinkGeneric 01/2022
1	Adenine FDA LinkGeneric 01/2022
1	InterleukinsIBA 11/2021
1	Phosphopyruvate Hydratase (Enolase)IBA 11/2021
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2021
1	EndotoxinsIBA 01/2021
1	Cadherins (E-Cadherin)IBA 01/2021
1	Tight Junction ProteinsIBA 01/2021
1	PH.3IBA 12/2020
1	LipidsIBA 12/2020
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2020
1	NLR ProteinsIBA 01/2020
1	Caspase 3 (Caspase-3)IBA 01/2019
1	Neurotensin Receptors (Neurotensin Receptor)IBA 01/2019
1	Interleukin-3 (Interleukin 3)IBA 01/2019
1	NeurotensinIBA 01/2019

Therapy/Procedure

88	Cardiopulmonary Resuscitation (CPR) 07/2022 - 01/2002
80	Resuscitation 07/2022 - 04/2002
11	Artificial Respiration (Mechanical Ventilation) 11/2021 - 07/2002
11	Induced Hypothermia 12/2020 - 03/2011
11	Ligation 01/2019 - 02/2006
8	Defibrillators (Defibrillator) 12/2013 - 04/2002
6	Punctures 01/2019 - 02/2006
4	Therapeutics 01/2021 - 01/2009
3	Intravenous Infusions 03/2011 - 11/2007
2	Ischemic Postconditioning 01/2018 - 01/2015
2	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 12/2011 - 01/2010
2	Induced Heart Arrest (Cardioplegia) 01/2008 - 03/2007
2	Injections 07/2002 - 04/2002